SMTL ID : 6qac.1

Human Butyrylcholinesterase in complex with (S)-2-(butylamino)-N-(3-cycloheptylpropyl)-3-(1H-indol-3-yl)propanamide

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.77 Å
Oligo State
monomer
Ligands
1 x NAG- FUC: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
1 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
1 x HUT: (2~{S})-2-(butylamino)-~{N}-(3-cycloheptylpropyl)-3-(1~{H}-indol-3-yl)propanamide(Non-covalent)
1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
4 x SO4: SULFATE ION(Non-functional Binders)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Meden, A. et al., Tryptophan-derived butyrylcholinesterase inhibitors as promising leads against Alzheimer's disease. Chem.Commun.(Camb.) (2019)
Release Date
2019-03-27
Peptides
Cholinesterase: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A

Cholinesterase

Related Entries With Identical Sequence

6qaa.1 | 6qab.1 | 6qad.1 | 6qae.1